(2003). MD: Colorectal malignancies in HIV-positive patients. Am Surg
(2003). Microsatellite analysis of Cryptosporidium hominis and C. parvum in Portugal: a preliminary study.
(1999). Mouse models for colorectal cancer. Oncogene
(1995). Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts.
(2004). Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.
(1981). Pohlenz JF: Staining of cryptosporidia by a modified Ziehl-Neelsen technique. Acta Vet Scand
(2006). Pozio E: Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis. Expert Rev Anti Infect Ther
(2004). Pozio E: Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro. Infect Immun
(2002). Recent advances in cryptosporidiosis: the immune response. Microbes Infect
(2004). RP: Cryptosporidiosis of the biliary tract mimicking pancreatic cancer in an AIDS patient. Rev Soc Bras Med Trop
(2007). Schaefer FW 3rd: Characterization of a Cryptosporidium muris infection and reinfection in CF-1 mice. Vet Parasitol
(1994). Schinazi RF: Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun
(1996). SCID mice and the study of parasitic disease. Clin Microbiol Rev
(1993). Shultz LD: The Severe Combined Immunodeficiency (scid) Mutation.
(2004). SJ: Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev
(1989). Takada S: Infectivity of Cryptosporidium muris (strain RN 66) in various laboratory animals. Parasitol Res
(2006). Taketo MM: Mouse models of gastrointestinal tumors. Cancer Sci
(2007). Telatynska-Smieszek B: Cryptosporidiosis in patients with colorectal cancer.
(2003). Thamsborg SM: Pathogenicity of Cryptosporidium parvum--evaluation of an animal infection model. Vet Parasitol
(2002). The global health burden of infection-associated cancers in the year
(2005). The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol
(2003). The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch
(1999). The pathogenesis of experimental infections of Cryptosporidium muris (strain RN 66) in outbred nude mice. Vet Parasitol
(2007). Tomic-Canic M: Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation.
(2002). Tzipori S: Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-g knockout mice.
(2005). Tzipori S: Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection. Parasitol Res
(2007). Wang TC: Inflammation, atrophy, and gastric cancer.
(2001). White AC Jr.: Expression of IL-15 and IL-4 in IFN-gammaindependent control of experimental human Cryptosporidium parvum infection. Cytokine